Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis. Wurster, S., Garcia, J. P., Wang, Y., Albert, N. D., Bharadwaj, U., Matula, L., Lewis, R. E., Evans, S. E., & Kontoyiannis, D. P. Proceedings of the National Academy of Sciences of the United States of America, 123(21), 2026. Cited by: 0; All Open Access; Green Open Access; Hybrid Gold Open Access
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis [link]Paper  doi  bibtex   
@ARTICLE{Wurster2026,
	author = {Wurster, Sebastian and Garcia, Jezreel Pantaleon and Wang, Yongxing and Albert, Nathaniel D. and Bharadwaj, Uddalak and Matula, Lauren and Lewis, Russell E. and Evans, Scott E. and Kontoyiannis, Dimitrios P.},
	title = {Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis},
	year = {2026},
	journal = {Proceedings of the National Academy of Sciences of the United States of America},
	volume = {123},
	number = {21},
	pages = {},
	doi = {10.1073/pnas.2512042123},
	url = {https://www.scopus.com/pages/publications/105039727459?origin=resultslist},
	type = {Article},
	publication_stage = {Final},
	source = {Scopus},
	note = {Cited by: 0; All Open Access; Green Open Access; Hybrid Gold Open Access}
}

Downloads: 0